tetano
Editor, Senior Moderator
JAMA Netw Open
. 2024 Oct 1;7(10):e2438918.
doi: 10.1001/jamanetworkopen.2024.38918. Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic
Jeremy Samuel Faust[SUP] 1 2 [/SUP], Benjamin Renton[SUP] 3 4 [/SUP], Tasce Bongiovanni[SUP] 5 [/SUP], Alexander Junxiang Chen[SUP] 5 [/SUP], Karen Dorsey Sheares[SUP] 6 7 [/SUP], Chengan Du[SUP] 8 [/SUP], Utibe R Essien[SUP] 9 [/SUP], Elena Fuentes-Afflick[SUP] 5 [/SUP], Trent Haywood[SUP] 10 [/SUP], Rohan Khera[SUP] 7 11 [/SUP], Terris King[SUP] 12 [/SUP], Shu-Xia Li[SUP] 8 [/SUP], Zhenqiu Lin[SUP] 8 [/SUP], Yuan Lu[SUP] 7 11 [/SUP], Andrew D A Marshall[SUP] 1 [/SUP], Chima D Ndumele[SUP] 13 [/SUP], Ijeoma Opara[SUP] 14 [/SUP], Tina Loarte-Rodriguez[SUP] 8 [/SUP], Mitsuaki Sawano[SUP] 8 [/SUP], Kekoa Taparra[SUP] 15 [/SUP], Herman A Taylor[SUP] 16 [/SUP], Karol E Watson[SUP] 17 [/SUP], Clyde W Yancy[SUP] 10 [/SUP], Harlan M Krumholz[SUP] 8 [/SUP]
Affiliations
Importance: The end of the COVID-19 public health emergency (PHE) provides an opportunity to fully describe pandemic-associated racial and ethnic mortality disparities. Age-specific excess mortality differences have important downstream implications, especially in minoritized race and ethnicity populations.
Objectives: To characterize overall and age-specific all-cause excess mortality by race and ethnicity during the COVID-19 PHE and assess whether measured differences reflected changes from prepandemic disparities.
Design, setting, and participants: This cross-sectional study analyzed data of all US residents and decedents during the COVID-19 PHE, aggregated by observed race and ethnicity (at time of death) and age. Statistical analysis was performed from March 2020 to May 2023.
Exposures: COVID-19 PHE period (March 2020 to May 2023).
Main outcomes and measures: All-cause excess mortality (incident rates, observed-to-expected ratios) and all-cause mortality relative risks before and during the PHE.
Results: For the COVID-19 PHE period, data for 10 643 433 death certificates were available; mean (SD) decedent age was 72.7 (17.9) years; 944 318 (8.9%) were Hispanic; 78 973 (0.7%) were non-Hispanic American Indian or Alaska Native; 288 680 (2.7%) were non-Hispanic Asian, 1 374 228 (12.9%) were non-Hispanic Black or African American, 52 905 (0.5%) were non-Hispanic more than 1 race, 15 135 (0.1%) were non-Hispanic Native Hawaiian or Other Pacific Islander, and 7 877 996 (74.1%) were non-Hispanic White. More than 1.38 million all-cause excess deaths (observed-to-expected ratio, 1.15 [95% CI, 1.12-1.18]) occurred, corresponding to approximately 23 million years of potential life lost (YPLL) during the pandemic. For the total population (all ages), the racial and ethnic groups with the highest observed-to-expected all-cause mortality ratios were the American Indian or Alaska Native (1.34 [95% CI, 1.31-1.37]) and Hispanic (1.31 [95% CI, 1.27-1.34]) populations. However, higher ratios were observed in the US population aged 25 to 64 years (1.20 [95% CI, 1.18-1.22]), greatest among the American Indian or Alaska Native (1.45 [95% CI, 1.42-1.48]), Hispanic (1.40 [95% CI, 1.38-1.42]), and Native Hawaiian or Other Pacific Islander (1.39 [95% CI, 1.34-1.44]) groups. In the total population aged younger than 25 years, the Black population accounted for 51.1% of excess mortality, despite representing 13.8% of the population. Had the rate of excess mortality observed among the White population been observed among the total population, more than 252 000 (18.3%) fewer excess deaths and more than 5.2 million (22.3%) fewer YPLL would have occurred.
Conclusions and relevance: In this cross-sectional study of the US population during the COVID-19 PHE, excess mortality occurred in all racial and ethnic groups, with disparities affecting several minoritized populations. The greatest relative increases occurred in populations aged 25 to 64 years. Documented differences deviated from prepandemic disparities.
. 2024 Oct 1;7(10):e2438918.
doi: 10.1001/jamanetworkopen.2024.38918. Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic
Jeremy Samuel Faust[SUP] 1 2 [/SUP], Benjamin Renton[SUP] 3 4 [/SUP], Tasce Bongiovanni[SUP] 5 [/SUP], Alexander Junxiang Chen[SUP] 5 [/SUP], Karen Dorsey Sheares[SUP] 6 7 [/SUP], Chengan Du[SUP] 8 [/SUP], Utibe R Essien[SUP] 9 [/SUP], Elena Fuentes-Afflick[SUP] 5 [/SUP], Trent Haywood[SUP] 10 [/SUP], Rohan Khera[SUP] 7 11 [/SUP], Terris King[SUP] 12 [/SUP], Shu-Xia Li[SUP] 8 [/SUP], Zhenqiu Lin[SUP] 8 [/SUP], Yuan Lu[SUP] 7 11 [/SUP], Andrew D A Marshall[SUP] 1 [/SUP], Chima D Ndumele[SUP] 13 [/SUP], Ijeoma Opara[SUP] 14 [/SUP], Tina Loarte-Rodriguez[SUP] 8 [/SUP], Mitsuaki Sawano[SUP] 8 [/SUP], Kekoa Taparra[SUP] 15 [/SUP], Herman A Taylor[SUP] 16 [/SUP], Karol E Watson[SUP] 17 [/SUP], Clyde W Yancy[SUP] 10 [/SUP], Harlan M Krumholz[SUP] 8 [/SUP]
Affiliations
- PMID: 39392630
- DOI: 10.1001/jamanetworkopen.2024.38918
Importance: The end of the COVID-19 public health emergency (PHE) provides an opportunity to fully describe pandemic-associated racial and ethnic mortality disparities. Age-specific excess mortality differences have important downstream implications, especially in minoritized race and ethnicity populations.
Objectives: To characterize overall and age-specific all-cause excess mortality by race and ethnicity during the COVID-19 PHE and assess whether measured differences reflected changes from prepandemic disparities.
Design, setting, and participants: This cross-sectional study analyzed data of all US residents and decedents during the COVID-19 PHE, aggregated by observed race and ethnicity (at time of death) and age. Statistical analysis was performed from March 2020 to May 2023.
Exposures: COVID-19 PHE period (March 2020 to May 2023).
Main outcomes and measures: All-cause excess mortality (incident rates, observed-to-expected ratios) and all-cause mortality relative risks before and during the PHE.
Results: For the COVID-19 PHE period, data for 10 643 433 death certificates were available; mean (SD) decedent age was 72.7 (17.9) years; 944 318 (8.9%) were Hispanic; 78 973 (0.7%) were non-Hispanic American Indian or Alaska Native; 288 680 (2.7%) were non-Hispanic Asian, 1 374 228 (12.9%) were non-Hispanic Black or African American, 52 905 (0.5%) were non-Hispanic more than 1 race, 15 135 (0.1%) were non-Hispanic Native Hawaiian or Other Pacific Islander, and 7 877 996 (74.1%) were non-Hispanic White. More than 1.38 million all-cause excess deaths (observed-to-expected ratio, 1.15 [95% CI, 1.12-1.18]) occurred, corresponding to approximately 23 million years of potential life lost (YPLL) during the pandemic. For the total population (all ages), the racial and ethnic groups with the highest observed-to-expected all-cause mortality ratios were the American Indian or Alaska Native (1.34 [95% CI, 1.31-1.37]) and Hispanic (1.31 [95% CI, 1.27-1.34]) populations. However, higher ratios were observed in the US population aged 25 to 64 years (1.20 [95% CI, 1.18-1.22]), greatest among the American Indian or Alaska Native (1.45 [95% CI, 1.42-1.48]), Hispanic (1.40 [95% CI, 1.38-1.42]), and Native Hawaiian or Other Pacific Islander (1.39 [95% CI, 1.34-1.44]) groups. In the total population aged younger than 25 years, the Black population accounted for 51.1% of excess mortality, despite representing 13.8% of the population. Had the rate of excess mortality observed among the White population been observed among the total population, more than 252 000 (18.3%) fewer excess deaths and more than 5.2 million (22.3%) fewer YPLL would have occurred.
Conclusions and relevance: In this cross-sectional study of the US population during the COVID-19 PHE, excess mortality occurred in all racial and ethnic groups, with disparities affecting several minoritized populations. The greatest relative increases occurred in populations aged 25 to 64 years. Documented differences deviated from prepandemic disparities.